Medifast

Medifast

MED· Manufacturing· Fiscal year ends in December

CEO pay in FY2025

Daniel R. Chard is the CEO of Medifast and was paid $5.6M in FY2025 (Dec), the same as the year before.

PayNo stock prices for these years
CEO pay is from each Medifast proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Daniel R. ChardFY2025
  2. 2James P. MaloneyFY2023
  3. 3Anthony E. TyreeFY2025
  4. 4Nicholas M. JohnsonFY2025
  5. 5Jason L. GrovesFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Medifast paid its 4 named executives $9.4M in total in FY2025 (Dec). CEO Daniel R. Chard was paid $5.6M of that.

Name
Daniel R. ChardChairman & Chief Executive Officer
Anthony E. TyreeFormer Chief Business Operations Officer
Nicholas M. JohnsonChief Field Operations Officer
Jason L. GrovesChief Legal Officer & Corporate Secretary
James P. MaloneyChief Financial OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Medifast. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board3

See all
  • Jeffrey J. BrownLead independent director · 10 yr on the boardIndependentAudit (Chair), Executive—Paid as an executive
  • Scott SchlackmanDirector · 10 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive
  • Andrea B. ThomasDirector · 6 yr on the boardIndependentCompensation, Corporate Governance (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    Medifast Former Chief Business Operations Officer pay rose 39% to $1.5M in FY2025 (Dec).
    DEF 14A
  2. Pay
    Medifast Division head pay fell 34% to $1.1M in FY2024 (Dec).
    DEF 14A
  3. Pay
    Medifast General counsel pay fell 33% to $1.1M in FY2024 (Dec).
    DEF 14A
  4. Pay
    Medifast CEO pay fell 20% to $5.6M in FY2024 (Dec).
    DEF 14A
  5. Pay
    Medifast Former Chief Business Operations Officer pay fell 34% to $1.1M in FY2024 (Dec).
    DEF 14A
  6. Pay
    Medifast Division head pay rose 42% to $1.7M in FY2023 (Dec).
    DEF 14A
  7. Pay
    Medifast Division head pay fell 15% to $1.2M in FY2022 (Dec).
    DEF 14A
  8. Pay
    Medifast General counsel pay rose 41% to $1.6M in FY2023 (Dec).
    DEF 14A
  9. Pay
    Medifast CFO pay rose 41% to $2.0M in FY2023 (Dec).
    DEF 14A
  10. Pay
    Medifast CFO pay fell 12% to $1.4M in FY2022 (Dec).
    DEF 14A
  11. Pay
    Medifast CEO pay rose 18% to $7.0M in FY2023 (Dec).
    DEF 14A
  12. Pay
    Medifast Former Chief Business Operations Officer pay rose 42% to $1.6M in FY2023 (Dec).
    DEF 14A
  13. Pay
    Medifast Former Chief Business Operations Officer pay fell 14% to $1.1M in FY2022 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 6, 2026FY2025
Annual report10-KFeb 17, 2026FY2025
Proxy statementDEF 14AApr 29, 2025FY2024
Annual report10-KFeb 18, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KFeb 20, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data